Tamiya, Ryosuke
Miyake, Masahiro http://orcid.org/0000-0001-7410-3764
Kido, Ai
Hiragi, Shusuke
Tamura, Hiroshi
Kuroda, Tomohiro
Tsujikawa, Akitaka
Article History
Received: 12 April 2020
Accepted: 3 December 2020
First Online: 18 March 2021
Conflicts of interest
: R. Tamiya, None; M. Miyake, Consultant fee, Lecture fee (Santen, Nevakar, Novartis, Alcon, HOYA, Kowa, Senju, Ellex, Johnson & Johnson, AMO); A. Kido, None; S. Hiragi, None; H. Tamura, Grant (Findex), Lecture fee, Non-financial support (Novartis), Non-financial support (Bayer, Santen); T. Kuroda, None; A. Tsujikawa, Grant, Consultant fee, Lecture fee (Canon, AMO, Wakamoto, Otsuka), Grant (Findex, Kowa, Pfizer, TOMEY, Taiho), Grant, Advisory Board fee (Santen, Senju, Alcon), Advisory Board fee (HOYA, Bayer, Novartis, Chugai, Astellas, Eisai, Daiich-Sankyo, Janssen, Kyoto Drug Discovery & Development, Allergan), Consultant fee, Lecture fee (Sanwa Kagaku Kenkyusho, Nitten, Otsuka).